Folgen
Michael Wiese
Michael Wiese
University of South Australia
Keine bestätigte E-Mail-Adresse
Titel
Zitiert von
Zitiert von
Jahr
Extended RAS mutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials
MJ Sorich, MD Wiese, A Rowland, G Kichenadasse, RA McKinnon, ...
Annals of Oncology 26 (1), 13-21, 2015
6002015
Patient barriers to and enablers of deprescribing: a systematic review
E Reeve, J To, I Hendrix, S Shakib, MS Roberts, MD Wiese
Drugs & aging 30, 793-807, 2013
5042013
Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer
A Rowland, MM Dias, MD Wiese, G Kichenadasse, RA McKinnon, ...
British journal of cancer 112 (12), 1888-1894, 2015
3742015
Review of deprescribing processes and development of an evidence‐based, patient‐centred deprescribing process
E Reeve, S Shakib, I Hendrix, MS Roberts, MD Wiese
British journal of clinical pharmacology 78 (4), 738-747, 2014
3742014
People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe
E Reeve, MD Wiese, I Hendrix, MS Roberts, S Shakib
Journal of the American Geriatrics Society 61 (9), 1508-1514, 2013
2612013
Clinical outcomes associated with medication regimen complexity in older people: a systematic review
BC Wimmer, AJ Cross, N Jokanovic, MD Wiese, J George, K Johnell, ...
Journal of the American Geriatrics Society 65 (4), 747-753, 2017
2242017
Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers
AM Hopkins, A Rowland, G Kichenadasse, MD Wiese, H Gurney, ...
British journal of cancer 117 (7), 913-920, 2017
1702017
Ant venom immunotherapy: a double-blind, placebo-controlled, crossover trial
SGA Brown, MD Wiese, KE Blackman, RJ Heddle
The Lancet 361 (9362), 1001-1006, 2003
1522003
Medication regimen complexity and polypharmacy as factors associated with all-cause mortality in older people: a population-based cohort study
BC Wimmer, JS Bell, J Fastbom, MD Wiese, K Johnell
Annals of pharmacotherapy 50 (2), 89-95, 2016
1452016
CYP2C19 Genotype Has a Greater Effect on Adverse Cardiovascular Outcomes Following Percutaneous Coronary Intervention and in Asian Populations Treated …
MJ Sorich, A Rowland, RA McKinnon, MD Wiese
Circulation: cardiovascular genetics 7 (6), 895-902, 2014
1382014
The benefits and harms of deprescribing
E Reeve, S Shakib, I Hendrix, MS Roberts, MD Wiese
Medical journal of Australia 201 (7), 386-389, 2014
1332014
Development and validation of the patients’ attitudes towards deprescribing (PATD) questionnaire
E Reeve, S Shakib, I Hendrix, MS Roberts, MD Wiese
International journal of clinical pharmacy 35, 51-56, 2013
1192013
Alterations in drug disposition in older adults
E Reeve, MD Wiese, AA Mangoni
Expert opinion on drug metabolism & toxicology 11 (4), 491-508, 2015
1102015
Benefits of deprescribing on patients’ adherence to medications
E Reeve, MD Wiese
International journal of clinical pharmacy 36, 26-29, 2014
1102014
Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors
E Reeve, JM Andrews, MD Wiese, I Hendrix, MS Roberts, S Shakib
Annals of Pharmacotherapy 49 (1), 29-38, 2015
932015
Medication regimen complexity and number of medications as factors associated with unplanned hospitalizations in older people: a population-based cohort study
BC Wimmer, JS Bell, J Fastbom, MD Wiese, K Johnell
Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2016
802016
Medication regimen complexity and unplanned hospital readmissions in older people
BC Wimmer, E Dent, JS Bell, MD Wiese, I Chapman, K Johnell, ...
Annals of Pharmacotherapy 48 (9), 1120-1128, 2014
732014
Immediate‐type hypersensitivity drug reactions
SF Stone, EJ Phillips, MD Wiese, RJ Heddle, SGA Brown
British journal of clinical pharmacology 78 (1), 1-13, 2014
722014
The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detection
IA Wahab, NL Pratt, MD Wiese, LM Kalisch, EE Roughead
Pharmacoepidemiology and drug safety 22 (5), 496-502, 2013
722013
Characterisation of major peptides in ‘jack jumper’ant venom by mass spectrometry
NW Davies, MD Wiese, SGA Brown
Toxicon 43 (2), 173-183, 2004
722004
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20